Is Hikma Pharmaceuticals PLC (HKMPY) a Buy, Sell, or Hold?
OTC : HKMPY
Hikma Pharmaceuticals PLC
$41.18 USD
-$1.16 (-2.74%)
- Volume
- 200
- Average Volume
- 161
- Market Capitalization
- $4.33B
- P/E Ratio
- 0.19
- Dividend Yield
- 4.01%
- Price Target
- Year High
- $55.33
- Year Low
- $31.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.45
- Current Ratio
- $1.82
Company Overview
OTC
Said Samih Taleb Darwazah
Drug Manufacturers - Specialty & Generic
Healthcare
HKMPY
9400
GB
USD
Liquidity Metrics
0.62
1.82
1.06
0.23
0.45
Sales & Valuation
$3.36B
1.30
1.75
22.36
1.77
Profitability
$3.62
$402.94M
12.00%
15.49%
15.83%
7.10%
P/E Metrics
0.19
0.00
0.00
Analyst Price Target & Rating
4/5
0 Analysts
%
Financial Health Scores
3.60
7/9
$1.19B
$5.67B
$3.06B
$1.22B
Key Metrics (TTM)
$5.63B
1.68
8.40
1.82
15.83%
10.21%
8.84%
4.47%
$22.03
190 days
Company Executives
| Name | Title |
|---|---|
| Said Samih Taleb Darwazah | Chief Executive Officer |
| Areb KURDI | VP, Group Financial Controller & Acting CFO |
| Bassam Wael Rushdi Kanaan | Executive Vice President of Corporate Development and M&A |
| Guy Featherstone | Associate Director of Investor Relations |
| Hussein Arkhagha | Chief People Officer |
| Julie Hill | Senior Vice President of Corporate Quality Compliance/Health & Safety |
| Patricia Bousfield | Chief Information Officer |
| Susan Ringdal | Executive Vice President of Strategic Planning & Global Affairs |
| Samuel Park | General Counsel |
| Khalid Walid Hussni Al Nabilsi | Deputy CEO of North America and Europe & Director |
| Mazen Samih Taleb Darwazeh | Executive Vice Chairman & Deputy CEO of MENA |
Poll Results
No votes yet today — be the first to share your view!
About Hikma Pharmaceuticals PLC (OTC:HKMPY) Stock
Hikma Pharmaceuticals PLC is a global pharmaceutical company that specializes in the development, production, commercialization, and distribution of a wide array of generic, branded, and in-licensed medicines. These pharmaceuticals are provided in various final dosage forms, including solid, semi-solid, liquid, and injectable formats. The company's business activities are organized into three core divisions: Injectables, Generics, and Branded products. The Injectables division primarily supplies generic injectable medications for hospital use. Its Generics segment focuses on offering oral and other non-injectable generic formulations to the retail market. The Branded segment, conversely, delivers branded generic drugs and products licensed from third parties to both retail consumers and ho ... spitals. Hikma's product portfolio addresses numerous therapeutic areas, such as anti-infectives, cardiovascular health, central nervous system conditions, diabetes, oncology, pain management, and respiratory illnesses. The company maintains a substantial international footprint, operating throughout the United Kingdom, the United States, the Middle East, North Africa, Europe, and other global markets. Founded in 1978, Hikma Pharmaceuticals PLC has its headquarters in London, UK.
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
2026-06-04 17:39:00
LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on today's unanimous decision by the Supreme Court of the United States effectively ending Amarin's patent infringement litigation against the company. "Hikma has long fought for patients and their access to safe, high-quality, and affordable medicines," said Sam Park, General Counsel, Hikma.
2026-06-01 13:19:28
Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio - Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Bedford, and other state and local partners, today announced plans for a significant expansion of Hikma's manufacturing operations in Ohio, reinforcing the company's commitment to the state's growing pharmaceutical and biomanufacturing industry.
Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
2026-04-23 06:51:32
Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war
2026-04-23 02:27:19
Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that, while it has faced some pressure on shipping, energy, and insurance costs due to the war in the Middle East, a key market for the firm, it was confident it could absorb the higher costs.
Frequently Asked Questions
-
What is the current Hikma Pharmaceuticals PLC (HKMPY) stock price?
-
Hikma Pharmaceuticals PLC(OTC:HKMPY) stock price is $41.18 in the last trading session. During the trading session, HKMPY stock reached the peak price of $55.33 while $31.8 was the lowest point it dropped to. The percentage change in HKMPY stock occurred in the recent session was --2.74% while the dollar amount for the price change in HKMPY stock was -$1.16.
-
HKMPY's industry and sector of operation?
-
The OTC listed HKMPY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of HKMPY?
-
Said Samih Taleb Darwazah | Chief Executive Officer
Areb KURDI | VP, Group Financial Controller & Acting CFO
Bassam Wael Rushdi Kanaan | Executive Vice President of Corporate Development and M&A
Guy Featherstone | Associate Director of Investor Relations
Hussein Arkhagha | Chief People Officer -
How many employees does HKMPY have?
-
Number of HKMPY employees currently stands at 9400. HKMPY operates from 1 New Burlington Place, London, GL W1S 2HR, GB.
-
Link for HKMPY official website?
-
Official Website of HKMPY is: https://www.hikma.com
-
How do I contact HKMPY?
-
HKMPY could be contacted at phone #44 20 7399 2760 and can also be accessed through its website. HKMPY operates from 1 New Burlington Place, London, GL W1S 2HR, GB.
-
How many shares of HKMPY are traded daily?
-
The average number of HKMPY shares traded daily for last 3 months was 161.
-
What is the market cap of HKMPY currently?
-
The market value of HKMPY currently stands at $4.33B with its latest stock price at $41.18